Australia markets close in 5 hours 6 minutes

4D Molecular Therapeutics, Inc. (FDMT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.53-0.72 (-2.97%)
At close: 04:00PM EDT
23.53 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,974
20,723
3,129
18,038
13,612
Operating expenses
Research development
76,281
97,096
80,253
61,360
53,038
Selling general and administrative
31,769
36,494
32,908
28,011
17,238
Total operating expenses
108,050
133,590
113,161
89,371
70,276
Operating income or loss
-106,076
-112,867
-110,032
-71,333
-56,664
Total other income/expenses net
-45
-181
-35
-121
-181
Income before tax
-105,198
-100,837
-107,494
-71,317
-56,693
Income from continuing operations
-105,198
-100,837
-107,494
-71,317
-56,693
Net income
-105,198
-100,837
-107,494
-71,317
-56,693
Net income available to common shareholders
-105,198
-100,837
-107,494
-71,317
-56,693
Basic EPS
-2.65
-
-3.32
-2.57
-8.82
Diluted EPS
-2.65
-
-3.32
-2.57
-8.82
Basic average shares
36,536
-
32,351
27,730
6,431
Diluted average shares
36,536
-
32,351
27,730
6,431